Evidence map

ReviewJournal of hypertension2017

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.

Thomas D Giles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28509722